HHS OIG promotes self disclosure protocol
This article was originally published in The Gray Sheet
Executive Summary
HHS Inspector General Daniel Levinson announces a new initiative for healthcare providers to resolve conduct that may otherwise result in civil monetary penalties for physician self-referral and anti-kickback violations. In an April 24 "open letter," Levinson says the proposal is intended to provide guidance to supplement the self-disclosure protocol, which the IG says can lead to issuance of certification of compliance agreements to settle healthcare fraud as an alternative to more extensive corporate integrity agreements. The OIG's 1998 self-disclosure protocol is a mechanism for healthcare providers to investigate, quantify and resolve potential fraud. The new self-disclosure initiative offers providers the ability to work collaboratively with OIG, the letter states...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.